![]() | |
Clinical data | |
---|---|
Other names | HS-25 |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C25H21F2NO3 |
Molar mass | 421.444 g·mol−1 |
|
Hyzetimibe is a pharmaceutical drug that inhibits cholesterol absorption. [1] [2] It targets the NPC1-like intracellular cholesterol transporter 1. [2]
In China, it is used as a lipid-lowering agent and it has efficacy similar to ezetimibe. [3]
![]() | |
Clinical data | |
---|---|
Other names | HS-25 |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C25H21F2NO3 |
Molar mass | 421.444 g·mol−1 |
|
Hyzetimibe is a pharmaceutical drug that inhibits cholesterol absorption. [1] [2] It targets the NPC1-like intracellular cholesterol transporter 1. [2]
In China, it is used as a lipid-lowering agent and it has efficacy similar to ezetimibe. [3]